Clinical Trial Update: The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests.

View source ↗

Summary

This clinical trial update evaluates urinary DKK3 as a biomarker to identify kidney transplant patients at high risk of allograft dysfunction earlier than curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Failure
• Renal Allograft Dysfunction

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Renal Transplant Failure | Status: NOT_YET_RECRUITING